Great West Life Assurance CO Myriad Genetics Inc Transaction History

Great West Life Assurance CO

  • $49.6 Billion
  • Q1 2024

A detailed history of Great West Life Assurance CO transactions in Myriad Genetics Inc stock. As of the latest transaction made, Great West Life Assurance CO holds 103,498 shares of MYGN stock, worth $2.69 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
103,498
Previous 96,375 7.39%
Holding current value
$2.69 Million
Previous $1.84 Million 19.78%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024
BUY
$17.59 - $23.59 $125,293 - $168,031
7,123 Added 7.39%
103,498 $2.2 Million
Q4 2023

Feb 13, 2024
BUY
$13.91 - $21.32 $17,749 - $27,204
1,276 Added 1.34%
96,375 $1.84 Million
Q3 2023

Nov 14, 2023
SELL
$15.99 - $23.22 $895 - $1,300
-56 Reduced 0.06%
95,099 $1.52 Million
Q2 2023

Aug 10, 2023
SELL
$17.56 - $23.76 $55,033 - $74,463
-3,134 Reduced 3.19%
95,155 $2.21 Million
Q1 2023

May 12, 2023
SELL
$15.26 - $23.75 $91,956 - $143,117
-6,026 Reduced 5.78%
98,289 $2.28 Million
Q4 2022

Feb 10, 2023
BUY
$14.51 - $20.99 $32,632 - $47,206
2,249 Added 2.2%
104,315 $1.51 Million
Q3 2022

Nov 01, 2022
BUY
$18.21 - $27.88 $1.86 Million - $2.85 Million
102,066 New
102,066 $1.95 Million
Q2 2022

Aug 09, 2022
BUY
$16.45 - $25.88 $167,016 - $262,759
10,153 Added 14.16%
81,847 $1.49 Million
Q1 2022

May 12, 2022
BUY
$22.67 - $28.01 $38,788 - $47,925
1,711 Added 2.44%
71,694 $1.85 Million
Q4 2021

Feb 14, 2022
BUY
$24.13 - $32.63 $58,249 - $78,768
2,414 Added 3.57%
69,983 $1.93 Million
Q3 2021

Nov 15, 2021
SELL
$29.97 - $36.66 $11,298 - $13,820
-377 Reduced 0.55%
67,569 $2.2 Million
Q2 2021

Aug 11, 2021
BUY
$25.39 - $32.61 $35,520 - $45,621
1,399 Added 2.1%
67,946 $2.07 Million
Q1 2021

May 17, 2021
SELL
$19.92 - $31.6 $169,738 - $269,263
-8,521 Reduced 11.35%
66,547 $2.03 Million
Q4 2020

Feb 16, 2021
SELL
$12.16 - $19.77 $133,261 - $216,659
-10,959 Reduced 12.74%
75,068 $1.48 Million
Q3 2020

Nov 17, 2020
BUY
$11.25 - $14.75 $963,056 - $1.26 Million
85,605 Added 20285.55%
86,027 $1.12 Million
Q3 2020

Nov 13, 2020
SELL
$11.25 - $14.75 $1.06 Million - $1.39 Million
-94,067 Reduced 99.55%
422 $5,000
Q2 2020

Aug 17, 2020
SELL
$10.69 - $16.49 $62,493 - $96,400
-5,846 Reduced 5.83%
94,489 $1.07 Million
Q1 2020

May 14, 2020
BUY
$9.78 - $29.53 $67,892 - $204,997
6,942 Added 7.43%
100,335 $1.43 Million
Q4 2019

Feb 11, 2020
BUY
$20.93 - $35.1 $1.95 Million - $3.28 Million
93,393 New
93,393 $2.54 Million
Q3 2019

Oct 25, 2019
SELL
$22.08 - $47.08 $2.15 Million - $4.58 Million
-97,224 Closed
0 $0
Q2 2019

Jul 31, 2019
SELL
$22.67 - $35.0 $26,229 - $40,495
-1,157 Reduced 1.18%
97,224 $0
Q1 2019

May 08, 2019
SELL
$26.93 - $34.7 $20,493 - $26,406
-761 Reduced 0.77%
98,381 $3.26 Million
Q4 2018

Feb 12, 2019
BUY
$27.23 - $45.56 $270,775 - $453,048
9,944 Added 11.15%
99,142 $2.66 Million
Q3 2018

Nov 13, 2018
SELL
$37.57 - $50.34 $82,052 - $109,942
-2,184 Reduced 2.39%
89,198 $4.1 Million
Q2 2018

Aug 10, 2018
SELL
$27.75 - $40.17 $38,239 - $55,354
-1,378 Reduced 1.49%
91,382 $3.41 Million
Q1 2018

May 10, 2018
BUY
$28.83 - $41.01 $53,566 - $76,196
1,858 Added 2.04%
92,760 $2.74 Million
Q4 2017

Feb 09, 2018
SELL
$28.45 - $37.14 $113,344 - $147,965
-3,984 Reduced 4.2%
90,902 $3.12 Million
Q3 2017

Nov 09, 2017
BUY
$24.01 - $36.2 $2.28 Million - $3.43 Million
94,886
94,886 $3.43 Million

Others Institutions Holding MYGN

# of Institutions
195
Shares Held
94.2M
Call Options Held
280K
Put Options Held
14.3K
View Full List

About MYRIAD GENETICS INC

MYGN Quotes by TradingView
  • Ticker MYGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 80,634,800
  • Market Cap $2.09B
  • Description
  • Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...
More about MYGN
Track This Portfolio

Track Great West Life Assurance CO Portfolio

Follow Great West Life Assurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

News

Stay updated on Great West Life Assurance CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email